Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004468 |
---|---|
Receipt number | R000005338 |
Scientific Title | Phase I/II study of gemcitabine/cisplatin/S-1(GCS) combination therapy for patients with advanced biliary tract cancer |
Date of disclosure of the study information | 2010/11/14 |
Last modified on | 2020/01/28 09:04:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/10/28 09:53:14 | ||
2 | Update | 2010/11/14 09:42:57 | Date of disclosure of the study information |
|
3 | Update | 2010/12/01 10:09:21 | Institute |
|
4 | Update | 2010/12/01 10:10:26 | Recruitment status |
|
5 | Update | 2010/12/01 10:11:39 | Public title Acronym |
|
6 | Update | 2013/08/03 15:33:37 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2013/08/03 15:34:08 | Recruitment status |
|
8 | Update | 2014/04/29 12:11:27 | Recruitment status |
|
9 | Update | 2014/04/29 12:17:11 | TEL Division name Division name Address Address TEL Division name Division name TEL |
|
10 | Update | 2020/01/28 09:04:11 | Recruitment status Date of IRB Last follow-up date |